Tag Archives: FDA


Published 18 Jun 2020

The exciting road ahead for pharmaceutical development

In these confusing, seemingly-endless days of lockdown, it’s important to have milestones to look forward to. We have a few of these coming up at Malvern Panalytical: two within the next couple of weeks!  As you may have already read…READ MORE >

Tags: , ,

Published 20 Dec 2018

Regulatory Hot Topics III

Joint Pharmaceutical Analysis Group; Royal Society of Chemistry, London Malvern Panalytical had pleasure in presenting a poster on USP<232> and ICH Q3D Elemental Impurities Standards for X-Ray Fluorescence Analysis at the Regulatory Hot Topics III, Joint Pharmaceutical Analysis Group at…READ MORE >

Tags: , , ,

Published 31 Aug 2017

Morphologically-Directed Raman Spectroscopy (MDRS)

GEN covers the role of MDRS in reducing the need for clinical bioequivalence endpoint studies     Raman spectroscopy and MDRS enable determination of the size and shape of specific components within a multi-component blend. This article followed the recent…READ MORE >

Tags: , , , ,

Published 22 Aug 2017

21CFR part 11 for the Zetasizer

Zetasizer: 21CFR? Electronic Record/Electronic Signature? Test Schedule?   What about 21CFR for the Zetasizer? The Malvern Zetasizer is an extremely versatile measurement system. By far the most systems are used in academic and industry research laboratories, for example in fundamental…READ MORE >

Tags: , , , ,

Published 14 Jun 2016

FDA highlights Malvern’s innovative MDRS technology for Complex Generic drug product development

MDRS Technology Finally!  After what has felt like one of the wettest and longest winters in memory here in the UK, we’re now heading into the long, mellow days of midsummer. But casting its miserable shadow over the barbecues, school…READ MORE >

Tags: , , ,

Subscribe